(Q43461615)

23 November 2017

title

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo (English)

1 reference

23 November 2017

Martin B Oleksiewicz

1

1 reference

23 November 2017

Inger Thorup

2

1 reference

23 November 2017

Henriette S Nielsen

3

1 reference

23 November 2017

Hanne V Andersen

4

1 reference

23 November 2017

Anne Charlotte Hegelund

5

1 reference

23 November 2017

Lars Iversen

6

1 reference

23 November 2017

Torben S Guldberg

7

1 reference

23 November 2017

Peter R Brinck

8

1 reference

23 November 2017

Ingrid Sjogren

9

1 reference

23 November 2017

Ulla K Thinggaard

10

1 reference

23 November 2017

Lis Jørgensen

11

1 reference

23 November 2017

Marianne B Jensen

12

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

23 November 2017

published in

Toxicologic Pathology

1 reference

23 November 2017

volume

33

1 reference

23 November 2017

issue

5

1 reference

23 November 2017

page(s)

552-560

1 reference

The effect of protein degradation on cellular growth characteristics

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Quantitative cytochemical aspects of a combined Feulgen-Naphthol Yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Signaling control of mRNA translation in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Everything you wanted to know about the bladder epithelium but were afraid to ask.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Drosophila S6 kinase: a regulator of cell size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

PPAR trilogy from metabolism to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

The relative effects of different types of growth factors on DNA replication, mitosis, and cellular enlargement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

p70s6k function is essential for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01926230500214657

10.1080/01926230500214657

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference